We are pleased to announce that @Oxana Polyakova, PhD, is joining IN8bio as Senior Vice President of Research & Development.
Dr. Polyakova is a recognized leader in γδ T cell biology and the discovery and development of γδ T cell engagers (TCEs), with 20 years of experience spanning oncology, immunology, cell therapies, antibodies, and engager-based therapeutics.
Join us in welcoming Oxana to the IN8bio team!
🔗Read the full press release below in the comments.
$INAB
ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche
https://t.co/t3LjdBsGdi
@NatureComms@sophpacz
🚨Today, in @NatureCancer, we show that CAR-T cells and CAR-NK cells contain the seeds of their own self-destruction. Disruption of a FAS-L/FAS circuit enhances CAR potency against liquid and solid cancers. https://t.co/afS9vRG4Ok @MSKCancerCenter@parkerici@MSK_DeptOfMed
Hi,my friends,long time no see. In the last several months,I totally dedicated time with my dear daughter. Now I ride bike onto the main road of γδ T research. In the next few years,I will study the roles of γδT cells in autoimmune diseases,esp the Vδ1 subset.
A 2023 study reveals cats have nearly 300 facial expressions—which may be due to their co-evolution with humans.
Learn more: https://t.co/kOx1FKT6iR #ScienceMagArchives@NewsfromScience
Registration for the Greater Bay Area Unconventional T cell Symposium will end this week; we are looking forward to seeing you in Hong Kong!
Free registration: https://t.co/5PtoVIWc21
Very proud of this one - just out in @NatImmunol: great coordination of the Portugal-UK team & colabs; and outstanding persistence of the co-first authors, @GJ_Fiala from my lab and @NitalSumaria from @DanPennington1 ‘s lab, over a pandemic and beyond! :))
https://t.co/SGoudl4mAE
Sharing the printed version of our paper on DNAM-1/ PVR-mediated AML recognition by Delta One T cells which just came out in @BloodJournal:
https://t.co/5IJ6zLifxx
Happy to share our latest paper by Sofia Mensurado et al, in collaboration with @Menendez_Lab, funded by @CaixaResearch (@FundlaCaixa), out as First Edition in @BloodJournal:
https://t.co/hoG9W99zvp
With #ASH23 getting closer, here are some interesting abstracts at the intersection of cell therapies, immunology, functional genomic screens, and single-cell genomics:
#ASH2023
1/
Epigenetic CRISPR screening in human T cells reveals that BATF3 overexpression enhances T cell function, reduces exhaustion, and boosts CAR T cell potency in both in vitro and in vivo tumor models. #NBThighlight https://t.co/fuO5KSBv8q